Publications by authors named "Roman Slysko"

Article Synopsis
  • Phlegmasia cerulea dolens (PCD) is a serious condition caused by massive deep vein thrombosis that can threaten both life and limbs, often requiring urgent treatment options such as endovascular therapy or surgical embolectomy in specific cases.
  • A patient case illustrated simultaneous PCD with acute limb ischemia, showing symptoms like abdominal pain, cyanosis, and motor deficits, leading to a successful combined surgical embolectomy to resolve the issues.
  • This report emphasizes that there are no formal guidelines for treating PCD and stresses the necessity for personalized treatment strategies and comprehensive care access.
View Article and Find Full Text PDF

True aneurysm of the radial artery is very rare. Aneurysmal expansion of arteries due to degenerative changes, possibly infections, primarily affects the abdominal and thoracic aorta, intra and extracranial sections of cerebral arteries, popliteal artery, and visceral arteries. Published literature does not address the aneurysm on the distal sections of the arteries of upper or lower limb.

View Article and Find Full Text PDF

Introduction: Pancreatoduodenectomy is an extensive procedure carrying risk of a number of postoperative complications. Of these the most common are surgical site infections (SSI), bleeding, delayed gastric emptying, and anastomotic leakage. However, the most serious complications are ones, that are rare, clinically hardly diagnosed, and if untreated, leading to the death of a patient.

View Article and Find Full Text PDF

Stem cell therapy has been proposed to be an alternative therapy in patients with critical limb ischemia (CLI), not eligible for endovascular or surgical revascularization. We compared the therapeutic effects of intramuscular (IM) and intra-arterial (IA) delivery of bone marrow cells (BMCs) and investigated the factors associated with therapeutic benefits. Forty-one patients (mean age, 66 ± 10 years; 35 males) with advanced CLI (Rutherford category, 5 and 6) not eligible for revascularization were randomized to treatment with 40 ml BMCs using local IM (n = 21) or selective IA infusion (n = 20).

View Article and Find Full Text PDF